Return On Assets in % of Aptevo Therapeutics Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aptevo Therapeutics Inc. quarterly/annual Return On Assets history and change rate from Q3 2016 to Q3 2025.
  • Aptevo Therapeutics Inc. Return On Assets for the quarter ending 30 Sep 2025 was -159 %, a 21.6% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Return On Assets for 2024 was -153 %, a 154% decline from 2023.
  • Aptevo Therapeutics Inc. annual Return On Assets for 2023 was -60.1 %, a 381% decline from 2022.
  • Aptevo Therapeutics Inc. annual Return On Assets for 2022 was 21.4 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Aptevo Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -159 -28.3 -21.6% 01 Jul 2025 30 Sep 2025
Q2 2025 -176 -57.6 -48.8% 01 Apr 2025 30 Jun 2025
Q1 2025 -176 -65.9 -60.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -153 -92.4 -154% 01 Oct 2024 31 Dec 2024
Q3 2024 -131 -79.2 -154% 01 Jul 2024 30 Sep 2024
Q2 2024 -118 -64.3 -119% 01 Apr 2024 30 Jun 2024
Q1 2024 -110 -163 -307% 01 Jan 2024 31 Mar 2024
Q4 2023 -60.1 -81.5 -381% 01 Oct 2023 31 Dec 2023
Q3 2023 -51.6 -66.4 -447% 01 Jul 2023 30 Sep 2023
Q2 2023 -53.8 -67.6 -491% 01 Apr 2023 30 Jun 2023
Q1 2023 53 +102 01 Jan 2023 31 Mar 2023
Q4 2022 21.4 +65.1 01 Oct 2022 31 Dec 2022
Q3 2022 14.9 +60.2 01 Jul 2022 30 Sep 2022
Q2 2022 13.8 +64 01 Apr 2022 30 Jun 2022
Q1 2022 -48.7 +13.9 +22.2% 01 Jan 2022 31 Mar 2022
Q4 2021 -43.6 +9.06 +17.2% 01 Oct 2021 31 Dec 2021
Q3 2021 -45.4 +10.7 +19.1% 01 Jul 2021 30 Sep 2021
Q2 2021 -50.2 -2.03 -4.21% 01 Apr 2021 30 Jun 2021
Q1 2021 -62.6 -12.9 -25.9% 01 Jan 2021 31 Mar 2021
Q4 2020 -52.7 +9.3 +15% 01 Oct 2020 31 Dec 2020
Q3 2020 -56.1 +11.4 +16.9% 01 Jul 2020 30 Sep 2020
Q2 2020 -48.2 +22.8 +32.1% 01 Apr 2020 30 Jun 2020
Q1 2020 -49.7 +15.6 +23.9% 01 Jan 2020 31 Mar 2020
Q4 2019 -62 +1.79 +2.81% 01 Oct 2019 31 Dec 2019
Q3 2019 -67.5 -16.4 -32.1% 01 Jul 2019 30 Sep 2019
Q2 2019 -71 -72 -7109% 01 Apr 2019 30 Jun 2019
Q1 2019 -65.4 -68.2 -2421% 01 Jan 2019 31 Mar 2019
Q4 2018 -63.8 -70.2 -1090% 01 Oct 2018 31 Dec 2018
Q3 2018 -51.1 -52.8 -3013% 01 Jul 2018 30 Sep 2018
Q2 2018 1.01 +115 01 Apr 2018 30 Jun 2018
Q1 2018 2.82 +106 01 Jan 2018 31 Mar 2018
Q4 2017 6.45 +106 01 Oct 2017 31 Dec 2017
Q3 2017 1.75 +96 01 Jul 2017 30 Sep 2017
Q2 2017 -114 01 Apr 2017 30 Jun 2017
Q1 2017 -103 01 Jan 2017 31 Mar 2017
Q4 2016 -99.1 01 Oct 2016 31 Dec 2016
Q3 2016 -94.2 01 Jul 2016 30 Sep 2016

Aptevo Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -153 -92.4 -154% 01 Jan 2024 31 Dec 2024
2023 -60.1 -81.5 -381% 01 Jan 2023 31 Dec 2023
2022 21.4 +65.1 01 Jan 2022 31 Dec 2022
2021 -43.6 +9.06 +17.2% 01 Jan 2021 31 Dec 2021
2020 -52.7 +9.3 +15% 01 Jan 2020 31 Dec 2020
2019 -62 +1.79 +2.81% 01 Jan 2019 31 Dec 2019
2018 -63.8 -70.2 -1090% 01 Jan 2018 31 Dec 2018
2017 6.45 +106 01 Jan 2017 31 Dec 2017
2016 -99.1 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.